Bothriechis Schlegelii Snake Venom Composition and Effects

Bothriechis Schlegelii snake venom is a complex mixture of bioactive compounds, including proteins and peptides. It's made up of over 20 different venom components, each with its own unique properties and functions.

The venom of Bothriechis Schlegelii contains a high concentration of hemotoxins, which are proteins that attack the blood and lymph systems of its victims. This makes the venom highly effective at immobilizing its prey.

One of the most interesting things about Bothriechis Schlegelii venom is its ability to cause renal failure in its victims. This is due to the presence of nephrotoxins, which are compounds that specifically target the kidneys and cause damage.

Check this out: Western Diamondback Rattlesnake Venom

Bothriechis schlegelii is a species of snake that can be found in the wild, and studying its behavior in its natural habitat is crucial for understanding its habits.

In the wild, Bothriechis schlegelii is a solitary animal and only comes together with other members of its species to mate.

It's worth noting that Bothriechis schlegelii is a non-venomous snake, which makes it safe to handle and observe.

A different take: Common Snapping Turtle Species

To gather data for this study, researchers employed a combination of qualitative and quantitative methods.

A comprehensive literature review was conducted, examining existing research on the topic to identify key themes and areas of focus.

The review included a total of 50 studies, published between 2010 and 2020, which provided a broad understanding of the subject matter.

The studies were sourced from academic databases, including Google Scholar and PubMed.

Data collection also involved conducting surveys among 100 participants, who provided demographic information and answered questions about their experiences with the topic.

The survey questions were designed to be clear and concise, with a response rate of 90% from participants.

Surveys were distributed online, using a digital platform, and responses were collected over a period of two weeks.

In addition to surveys, researchers conducted in-depth interviews with 20 experts in the field, who shared their insights and opinions on the topic.

Interviews were recorded and transcribed for analysis, with a total of 10 hours of audio data collected.

The data was analyzed using a combination of thematic analysis and statistical methods, with results presented in a clear and concise manner.

Zymography is a powerful tool for detecting proteolytic and hyaluronidase activities in venoms. It's a method that's been used to assay activities such as protease, hyaluronidase, and PLA2.

To detect proteolytic and hyaluronidase activities, researchers used casein, gelatin, fibrinogen, and hyaluronic acid as substrates. These substrates are commonly used in zymography due to their ability to be broken down by specific enzymes.

Bj, BsCo, and BsCR showed different profiles for gelatinolytic activity, with notable differences in their enzymatic activities. For example, Bj showed high gelatinolytic activity above 46 kDa, while BsCo and BsCR had similar profiles with bands mainly between 75 and 23 kDa.

Casein was also used as a substrate to detect proteolytic activity, and the results were quite interesting. BsCo showed enzymes around 60 kDa that hydrolyzed casein, while BsCR showed activity above 63 kDa and another intense area at 40 kDa.

Fibrinogenolytic activity was observed in BsCR and BsCo, with components around 50 to 37 kDa and between 33 and 21 kDa. However, Bj showed fibrinogenolytic areas around 30 to 27 kDa.

Hyaluronidase activity was also detected in BsCR and BsCo, with a stronger activity observed in BsCR compared to BsCo. In contrast, Bj did not hydrolyze hyaluronic acid.

PLA2 activity was measured using a specific protocol, and the results showed that BsCo and BsCR had similar PLA2 activity, which was much higher than Bj. The specific activities for BsCo, BsCR, and Bj were 1273, 1255, and 33 U/mg, respectively.

Cross-reactivity of antivenom is a critical factor in determining its effectiveness. It's observed that BAV has intense cross-reactivity with various venoms.

BAV's antibody titers against different venoms are remarkably high, with 256,000 against BsCo and BsCR, and 1,024,000 against Bj venom. This suggests a strong recognition of venom components by BAV.

Western blotting reveals that BAV recognizes venom components around 150 kDa, between 75 and 50 kDa, and around 35 kDa in BsCo and BsCR. It's worth noting that these molecular masses are quite distinct.

The recognition of bands between 250 to 15 kDa in Bj venom by BAV is also noteworthy. This indicates a broad range of venom components that BAV can bind to.

In contrast, IgGs from NHS do not recognize any components of the venoms, highlighting the specificity of BAV's cross-reactivity.

I'd like to walk you through Table 1, which gives us a glimpse into the lethality of B. jararaca and B. schlegelii snake venoms from Colombia and Costa Rica.

The table shows the mortality rates of animals injected with different doses of venom. For example, 0 out of 6 animals died after being injected with 10 µg of B. jararaca venom.

Here's a breakdown of the mortality rates for each venom dose:

The LD50 (lethal dose 50%) values are also provided, which give us an idea of the amount of venom required to kill half of the animals. For B. jararaca venom, the LD50 is 34.8 µg/animal, while for B. schlegelii venom from Colombia, it's 184.8 µg/animal.

The venom of Bothriechis schlegelii, also known as the Schlegel's keelback, is quite fascinating. The electrophoretic profiles of its venom, as seen in Figure 2, show distinct differences from that of B. jararaca.

The venom of B. schlegelii from Colombia (BsCo) and Costa Rica (BsCR) has strong PLA2 activity, as evident in Figure 4. This is a significant finding, as PLA2 activity is a key characteristic of snake venom.

In terms of nociceptive activity, the venom of B. schlegelii from Colombia (BsCo) and Costa Rica (BsCR) was found to be highly potent, as shown in Figure 8. This is a crucial aspect of understanding the venom's potential effects on humans and animals.

The neutralization of nociceptive activity by anti-Bothrops antivenom (BAV) was also observed in Figure 8. This is a promising development, as it suggests that antivenom could be an effective treatment for bites from B. schlegelii.

Bothriechis schlegelii, the venom of this snake, has been found to cause edematogenic and hemorrhagic effects in mice.

Edematogenic activity, which is the ability to cause swelling, was evaluated in mice by plethysmometry. The venom caused significant swelling in all concentrations used up to 48 h, with the highest dose of 8 µg inducing the most severe and persistent swelling.

The edematogenic activity of the venom was also found to be neutralized by BAV, with values higher than 60% at 0.5 and 1 h and above 80% after 2 h. However, the neutralization was not complete, with some swelling still present after 2 h.

The hemorrhagic activity of the venom was evaluated by measuring the area of hemorrhagic spots after injection. The venom caused hemorrhaging in mice, with the minimum hemorrhagic dose (MHD) being 0.6 µg for Bj, 3.9 µg for BsCR, and 14.2 µg for BsCo.

BAV was found to completely neutralize the hemorrhagic activity of the venom, with all three doses tested (80, 40, and 20 µL) neutralizing two MHD of all three venoms tested.

Edematogenic activity was evaluated in mice by plethysmometry at different times (0.5, 1, 2, 4, 24, 48, and 72 h) as the difference of foot pad volume between the right foot paw injected with either PBS or different doses of BsCo, BsCR, and Bj.

Bj used as a positive control evoked severe and persistent paw swelling in all concentrations of venoms used up to 48 h.

Edema-forming activity was induced by BsCo and BsCR in all concentrations tested during the initial time periods, reaching a maximum at 0.5 and 1 h.

The edema induced by BsCo decreased significantly at 4 h, with values similar to those injected with PBS, while BsCR-induced edema remained evident at 4 h with the dose of 8 µg.

BAV partially inhibited the edema induced by Bj, with values higher than 60% at 0.5 and 1 h and above 80% after 2 h.

Edema caused by BsCo was better neutralized (around 70%) only in 2 h with 25 µL of BAV.

Edema was inhibited partially by all doses of BAV at 2 h (range 26%–63%) and 4 h (above 70%) when BsCR was incubated with BAV.

At 24 h, edema in the paw of the animals injected with BAV + BsCR was not detected.

A unique perspective: Big 4 Snakes in India

Hemorrhagic activity was evaluated by injecting different doses of BsCo, BsCR, and Bj into mice, with the minimum hemorrhagic dose (MHD) being the dose that causes a hemorrhagic area of 1 cm.

The MHD for BsCo was 14.2 µg, for BsCR it was 3.9 µg, and for Bj it was 0.6 µg.

BsCR was found to be more hemorrhagic than BsCo, and both of them were less hemorrhagic than Bj.

All three doses of BAV (80, 40, and 20 µL) tested completely neutralized two MHD of all three venoms tested.

The hemorrhagic activity was measured by the method described by Kondo et al. with some modifications, where mice were sacrificed and skins were excised 2 hours later to measure the areas of hemorrhagic spots.

PBS was used as a negative control, and NHS or PBS was used as a positive control to show hemorrhagic activity.

The lethality of Bothriechis schlegelii's venom is a topic of interest when studying this species.

Bj, the venom of Bothriechis schlegelii, has a median lethal dose (LD50) of 1.74 mg/kg.

BsCR, another venom, was more lethal than BsCo, with an LD50 of 5.60 mg/kg.

BsCo has an LD50 of 9.24 mg/kg.

Bj is more lethal than both BsCo and BsCR.

The lethal activity of the venoms was determined by injecting different concentrations into mice and observing mortality within 48 hours.

The antivenom, BAV, was able to protect 75% of animals injected with BsCR and 86% of animals injected with BsCo.

All animals injected with Bj were protected by BAV.

The neutralization experiments involved incubating the LD50 of each venom with BAV for 30 minutes, then injecting the mixture into mice.

The observations showed that BAV was effective in neutralizing the venoms.

As we delve into the fascinating world of Bothriechis schlegelii, it's clear that these snakes have some remarkable characteristics.

Bothriechis schlegelii is a species of snake that is endemic to Central America.

One of the most interesting things about these snakes is their habitat, which ranges from dry to humid forests.

Their diet consists mainly of small mammals and birds, making them an important part of their ecosystem.

Bothriechis schlegelii is a relatively small snake, typically growing to an average length of 1.5 meters.

In the wild, these snakes are generally solitary animals, only coming together for mating.

Their venom is hemotoxic, meaning it can cause damage to the tissues and organs of their victims.

Bothriechis schlegelii is listed as a species of "Least Concern" on the IUCN Red List, indicating a relatively stable population.